Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Clinical Trial Details for At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions


Sanguine Biosciences
NCT ID: NCT01931644
Last Updated: October 4, 2019

The Study at a Glance

  • Status: Recruiting
  • Phase:
  • Gender: All
  • Age: 18 Years - 100 Years
  • Condition:
    • All Diagnosed Health Conditions
    • ADD/ADHD
    • Alopecia Areata
    • Ankylosing Spondylitis
    • Asthma
    • Atopic Dermatitis Eczema
    • Beta Thalassemia
    • Bipolar Disorder
    • Breast Cancer
    • Celiac Disease
    • Cervical Cancer
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Chronic Kidney Diseases
    • Chronic Obstructive Pulmonary Disease
    • Colon Cancer
    • Colorectal Cancer
    • Crohn's Disease
    • Cystic Fibrosis
    • Depression
    • Diabetes Mellitus
    • Duchenne Muscular Dystrophy
    • Endometriosis
    • Epilepsy
    • Facioscapulohumeral Muscular Dystrophy
    • G6PD Deficiency
    • General Anxiety Disorder
    • Hepatitis B
    • Hereditary Hemorrhagic Telangiectasia
    • HIV/AIDS
    • Human Papilloma Virus
    • Huntington's Disease
    • Idiopathic Thrombocytopenic Purpura
    • Insomnia
    • Kidney Cancer
    • Leukemia
    • Lung Cancer
    • Lupus Nephritis
    • Lymphoma
    • Melanoma
    • Multiple Myeloma
    • Multiple Sclerosis
    • Myositis
    • Myotonic Dystrophy
    • Ovarian Cancer
    • Pancreatic Cancer
    • Parkinson's Disease
    • Polycystic Kidney Diseases
    • Prostate Cancer
    • Psoriasis
    • Psoriatic Arthritis
    • Rosacea
    • Scleroderma
    • Sickle Cell Anemia
    • Sickle Cell Trait
    • Sjogren's Syndrome
    • Skin Cancer
    • Spinal Muscular Atrophy
    • Systemic Lupus Erythematosus
    • Thrombotic Thrombocytopenic Purpura
    • Trisomy 21
    • Ulcerative Colitis
  • Study Type: Observational
  • Intervention:
  • Lead Sponsor: Sanguine Biosciences
  • Location: Not Provided

Official Title

A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Purpose

We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.

Eligibility

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

All

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Study Population

Diagnosed with a health condition

Criteria

Inclusion Criteria:

– All adults 18-100 years old

– Able to provide proof of diagnosis

– Live in USA

Exclusion Criteria:

– Younger than 18 years old

– Receipt of blood products within 30 days of study blood collection

– Receipt of investigational drug within 30 days of study blood collection

Additional Information, Locations & Contacts

Sponsors & Collaborators

Sanguine Biosciences

Investigators

Principal Investigator: Houman Hemmati, MD

Sanguine Biosciences

Please refer to this study by its ClinicalTrials.gov identifier: NCT01931644

Location

Contacts

Sanguine Biosciences

Los Angeles, California 91403

United States

Carolyn Bidwell

study@sanguinebio.com